UNIGE document Scientific Article
previous document  unige:144120  next document
add to browser collection
Title

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic hcv infection: a meta-analysis

Authors
Lampertico, Pietro
Carrión, Jose A
Curry, Michael
Turnes, Juan
Cornberg, Markus
Brown, Ashley
Persico, Marcello
show hidden authors show all authors [1 - 15]
Published in Journal of Hepatology. 2020, vol. 72, no. 6, p. 1112-1121
Abstract Glecaprevir/pibrentasvir is approved for treating adults infected with HCV genotypes 1-6. In clinical trials, glecaprevir/pibrentasvir was associated with high rates of sustained virologic response at post-treatment week 12 (SVR12) and was well tolerated. A systematic review and meta-analysis of the real-world effectiveness and safety of glecaprevir/pibrentasvir were undertaken.
Identifiers
PMID: 32061651
Full text
Article (Published version) (432 Kb) - public document Free access
Structures
Research group Etudes et traitement de l'hépatite C et B (554)
Citation
(ISO format)
LAMPERTICO, Pietro et al. Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic hcv infection: a meta-analysis. In: Journal of Hepatology, 2020, vol. 72, n° 6, p. 1112-1121. doi: 10.1016/j.jhep.2020.01.025 https://archive-ouverte.unige.ch/unige:144120

43 hits

26 downloads

Update

Deposited on : 2020-11-04

Export document
Format :
Citation style :